In focal segmental glomerulosclerosis (FSGS) patients, COL4A3 and COL4A4 were frequently not tested, resulting in a missed molecular diagnosis in some patients and inappropriate genetic counseling.10 Here, COL4A4 is linked to focal segmental glomerulosclerosis.